•
Jun 30, 2012

ResMed Q4 2012 Earnings Report

Total Revenue
$1.37B
Previous year: $342M
+300.3%
EPS
$0.53
Previous year: $0.38
+39.5%
Gross Profit
$226M
Previous year: $199M
+13.9%
Cash and Equivalents
$810M
Previous year: $735M
+10.1%
Free Cash Flow
$84.9M
Previous year: $56.9M
+49.3%
Total Assets
$2.14B
Previous year: $2.07B
+3.3%

ResMed

ResMed